Your browser doesn't support javascript.
loading
Aerosol Particle Size Influences the Infectious Dose and Disease Severity in a Golden Syrian Hamster Model of Inhalational COVID-19.
Boydston, Jeremy A; Biryukov, Jennifer; Yeager, John J; Zimmerman, Heather A; Williams, Gregory; Green, Brian; Reese, Amy L; Beck, Katie; Bohannon, Jordan K; Miller, David; Freeburger, Denise; Graham, Amanda; Wahl, Victoria; Hevey, Michael C; Dabisch, Paul A.
Affiliation
  • Boydston JA; National Biodefense Analysis and Countermeasures Center (NBACC), Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
  • Biryukov J; National Biodefense Analysis and Countermeasures Center (NBACC), Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
  • Yeager JJ; National Biodefense Analysis and Countermeasures Center (NBACC), Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
  • Zimmerman HA; National Biodefense Analysis and Countermeasures Center (NBACC), Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
  • Williams G; National Biodefense Analysis and Countermeasures Center (NBACC), Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
  • Green B; National Biodefense Analysis and Countermeasures Center (NBACC), Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
  • Reese AL; National Biodefense Analysis and Countermeasures Center (NBACC), Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
  • Beck K; National Biodefense Analysis and Countermeasures Center (NBACC), Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
  • Bohannon JK; National Biodefense Analysis and Countermeasures Center (NBACC), Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
  • Miller D; National Biodefense Analysis and Countermeasures Center (NBACC), Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
  • Freeburger D; National Biodefense Analysis and Countermeasures Center (NBACC), Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
  • Graham A; National Biodefense Analysis and Countermeasures Center (NBACC), Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
  • Wahl V; National Biodefense Analysis and Countermeasures Center (NBACC), Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
  • Hevey MC; National Biodefense Analysis and Countermeasures Center (NBACC), Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
  • Dabisch PA; National Biodefense Analysis and Countermeasures Center (NBACC), Operated by Battelle National Biodefense Institute for the US Department of Homeland Security, Frederick, Maryland, USA.
J Aerosol Med Pulm Drug Deliv ; 36(5): 235-245, 2023 10.
Article in En | MEDLINE | ID: mdl-37262184
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Aerosol Med Pulm Drug Deliv Journal subject: TERAPIA POR MEDICAMENTOS Year: 2023 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Aerosol Med Pulm Drug Deliv Journal subject: TERAPIA POR MEDICAMENTOS Year: 2023 Document type: Article Affiliation country: United States Country of publication: United States